Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Nausea in Familial Dysautonomia
NCT02608931Phase 2Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Nov 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in Familial dysautonomia (FD), sponsored by NYU Langone Health. Planned start Nov 2015; status: withdrawn.
02
Drugs
dronabinol
03
Conditions
Familial dysautonomia (FD)
Beyond the preview
Go deeper on NCT02608931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02608931.